太多的SAMA,太多的恶化:在喘中呼吁谨慎
Fernando M Navarro Ros1, José David Maya Viejo2
1Centro de Salud Plaza Segovia, Plaza Segovia s/n, 46017 Valencia, Spain.
Journal of clinical medicine
|July 29, 2025
概括
在喘中频繁使用短效肌抗体 (SAMA) 显著增加了恶化的风险和医疗保健的使用. 追踪SAMA使用可以帮助比以前识别的更早地识别不稳定的喘.
科学领域:
- 肺部病理学 肺部病理学
- 现实世界的证据.
- 药物监督 药物监督 药物监督
背景情况:
- 过度依赖短效β2-激动剂 (SABAs) 与喘不良结果有关.
- 频繁使用短效肌酸抗剂 (SAMA) 对喘恶化的影响尚不清楚.
- 目前的喘指南缺乏对SAMA过度使用的建议.
研究的目的:
- 为了对SAMA在喘中的过度使用进行第一个现实世界的分析.
- 量化SAMA使用与喘恶化风险之间的关联.
- 为了比较SAMA使用与SABA使用对喘结果的预测值.
主要方法:
- 在西班牙国家卫生系统中对132名成人喘患者进行了回顾性多中心队列研究.
- 电子健康记录 (EHR) 的分析使用负二项式回归和引导模拟.
- 应用交互和值模型来确定SAMA使用切断值及其对结果的影响.
主要成果:
- 萨马的使用独立地与每桶恶化的频率增加了19.2%.
- 频繁使用SAMA (≥2.5/年) 与经历≥1次恶化的几率增加了近六倍.
- 增加的SAMA使用与更高的医疗保健利用相关,包括呼吸咨询和全身皮质类固醇和抗生素的处方.
结论:
- 过度使用SAMA是一种重要的,数字可追溯的喘不稳定性的指标.
- 研究结果表明,SAMA跟踪可以在喘管理工具中补充SABA监测.
- 通过SAMA使用早期识别失控的喘可以指导及时进行治疗调整.
相关概念视频
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
389
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
389
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:24Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
314
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
314